| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/13/2000 | EP1035137A1 Method for the reductive amination of polysaccharides |
| 09/13/2000 | EP1035133A2 Fusion proteins comprising carriers that can induce a dual immune response |
| 09/13/2000 | EP1035131A1 Process for the preparation of n2 -(1(s)-carboxy-3-phenylpropyl)-l-lysyl-l-proline |
| 09/13/2000 | EP1034795A2 Conjugates of lipids and biologically active compounds |
| 09/13/2000 | EP1034791A1 Anti-hypoxic and anti-ischemic drug |
| 09/13/2000 | EP1034790A2 HIV therapy |
| 09/13/2000 | EP1034789A1 Type-2 chemokine binding proteins and methods of use therefor |
| 09/13/2000 | EP1034326A1 Process for the production of protein fibres and products thereof |
| 09/13/2000 | EP1034301A1 Inhibition of an fgf-binding protein using ribozymes |
| 09/13/2000 | EP1034296A1 ribH POLYPEPTIDES AND POLYNUCLEOTIDES |
| 09/13/2000 | EP1034295A1 ribA |
| 09/13/2000 | EP1034279A1 Human irak-2, a human interleukin-1 receptor associated kinase-2 |
| 09/13/2000 | EP1034277A2 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS) |
| 09/13/2000 | EP1034276A1 Novel era |
| 09/13/2000 | EP1034275A1 VACCINES FOR BLOCKING TRANSMISSION OF $i(PLASMODIUM VIVAX) |
| 09/13/2000 | EP1034273A1 Histamine and serotonin binding molecules |
| 09/13/2000 | EP1034272A1 A cDNA ENCODING C6 $g(b)-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN |
| 09/13/2000 | EP1034270A1 Compositions and methods of use of het |
| 09/13/2000 | EP1034269A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes |
| 09/13/2000 | EP1034268A1 G-protein coupled receptors and uses therefor |
| 09/13/2000 | EP1034267A1 Compositions and methods for inducing gene expression |
| 09/13/2000 | EP1034265A1 Human cdc10 homolog |
| 09/13/2000 | EP1034264A1 Splice variants for human 5-ht 4? serotonin receptor and their applications, in particular for screening |
| 09/13/2000 | EP1034256A1 Anticoagulant test |
| 09/13/2000 | EP1034207A1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES |
| 09/13/2000 | EP1034187A1 $i(IN VITRO) AND $i(IN VIVO) GROWTH-PROMOTING PROTEINS AND PEPTIDES FOR KIDNEY EPITHELIAL CELLS |
| 09/13/2000 | EP1034186A2 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment |
| 09/13/2000 | EP1034185A2 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 09/13/2000 | EP1034182A1 Inhibition of nuclear import by backbone cyclic peptide analogs |
| 09/13/2000 | EP1034007A1 A ONE DOSE SYRINGE, COMPRISING A FREEZE-DRIED PROTEIN COMPOSITION, FOR ADMINISTERING OF A VOLUME LESS THAN 0.5 ml |
| 09/13/2000 | EP1034003A1 Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy |
| 09/13/2000 | EP1034002A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor |
| 09/13/2000 | EP1034001A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
| 09/13/2000 | EP1033999A1 Compositions of leukaemia inhibitory factor |
| 09/13/2000 | EP1033998A1 Method of suppressing beta-amyloid-related changes in alzheimer's disease |
| 09/13/2000 | EP1033997A1 Method of mobilizing hematopoietic stem cells |
| 09/13/2000 | EP1033996A1 Prevention and treatment of amyloidogenic disease |
| 09/13/2000 | EP1033992A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 09/13/2000 | EP1033973A1 Encapsulation method |
| 09/13/2000 | EP1033971A1 Combined chemo-immunotherapy with liposomal drugs and cytokines |
| 09/13/2000 | EP1033953A1 Method of cross-linking keratin-based films, sheets, and bulk materials |
| 09/13/2000 | EP1033910A1 Dipeptide apoptosis inhibitors and the use thereof |
| 09/13/2000 | EP0957902A4 System for genetically treating cardiac conduction disturbances |
| 09/13/2000 | EP0938557B1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 09/13/2000 | EP0814834B1 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies directed against said immunogens, preparation method therefor, and pharmaceutical compositions containing the same |
| 09/13/2000 | EP0772624B1 Interleukin-15 |
| 09/13/2000 | EP0746331B1 Convertible microemulsion formulations |
| 09/13/2000 | EP0674652B1 Dolastatin analog |
| 09/13/2000 | CN1266459A Method and reagents for vaccination which generate a CD8 T cell immune response |
| 09/13/2000 | CN1266371A Stable insulin formulations |
| 09/13/2000 | CN1266097A Process for preparing recombinant natookinase |
| 09/13/2000 | CN1265921A Erythropoiesis for treating anemia of family and raised animals |
| 09/13/2000 | CN1265920A Medicinal composition containing cyclosporin |
| 09/13/2000 | CN1265891A Technoogies for producing inhibitant of tumor blood vessel formation |
| 09/13/2000 | CN1056383C Chinese trichosanthes protein, preparation method and use in pharmacy |
| 09/13/2000 | CN1056381C Active peptide for promoting immunization function and usage thereof |
| 09/12/2000 | USRE36866 Anti-aids immunotoxins |
| 09/12/2000 | US6118045 Mammal having transgene with promoter and enhancer from same mammary gland specific gene, signal sequence for mammary secretory cells, and recombinant dna coding for acid alpha glucosidase; processed/secreted enzyme for pompe's disease |
| 09/12/2000 | US6118043 Bone replacement material with FGF |
| 09/12/2000 | US6117991 Plasmid pav2-htsh-beta on deposit as atcc 75505; for recombinant production, diagnosis and therapy of human thyroid cancer; anticarcinogenic agents |
| 09/12/2000 | US6117989 Human calcium-binding proteins |
| 09/12/2000 | US6117985 Negative selection process for enriching and recovering non-hematopoietic cells by reacting sample with antibodies which bind glycophorin a, cd2, cd14, cd16, cd38, cd45 and cd66b; removing bound cells; recovering tumor cells |
| 09/12/2000 | US6117984 Growth hormone crystals and a process for production of these GH-crystals |
| 09/12/2000 | US6117982 Microbead coupled with binding molecules which lack fc portions and are specific for cd2, cd3 or other t cell receptor-linked components, cd4, cd5 or cd8; anticarcinogenic agents and treatment of infections |
| 09/12/2000 | US6117980 Humanized anti-IL-8 monoclonal antibodies |
| 09/12/2000 | US6117978 Protein having at least 63% identity to human protein having defined amino acid sequence; for diagnosis and therapy of alzheimer's disease; drug screening |
| 09/12/2000 | US6117975 Amino acid and nucleotide sequences; for therapy |
| 09/12/2000 | US6117974 For screening bioactive molecules; compounds have n-alpha derivative amino acids linked by bridging group of disulfide, amide, thioether, thioester, imine, ether, or alkene to terminus located at a side chain or a backbone nitrogen |
| 09/12/2000 | US6117899 Use of R-(+)-α-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as its sequelae |
| 09/12/2000 | US6117897 1/2 sulfate of a [(S) -1- [(S) -2- [(trans-4- aminocyclohexylmethyl) carbamoyl]pyrrolidine-1-carbonyl]- 2-isopropylthio-2-methylpropyl]carbamic acid propyl ester |
| 09/12/2000 | US6117896 Methods for regulating transcription factors |
| 09/12/2000 | US6117888 Thrombin inhibitors |
| 09/12/2000 | US6117887 Inhibition of 26S and 20S proteasome by indanones |
| 09/12/2000 | US6117858 For specific delivery of biologically active substances to achieve lower doses and for improved efficacy with drugs such as oligonucleotides and polynucleotides with problems in achieving therapeutic concentrations at targeted organs |
| 09/12/2000 | US6117853 Cerebration improver |
| 09/12/2000 | US6117850 Mobilization of peripheral blood precursor cells by β(1,3)-glucan |
| 09/12/2000 | US6117848 Antisense oligonucleotide inhibition of ras |
| 09/12/2000 | US6117847 For use in inhibiting the function of nucleic acid molecules encoding protein kinase c (pkc), ultimately modulating the amount of pkc produced; for treating cancer, inflammation, psoriasis |
| 09/12/2000 | US6117841 Used to treat stroke, cerebral ischemia, pain, head trauma or epilepsy |
| 09/12/2000 | US6117840 Inhibits binding between vla-4 receptor expressed on inflammatory leukocytes and fibronectin cs-1 peptide expressed on endothelial cells that are involved in immunoinflammatory disease states |
| 09/12/2000 | US6117839 For increasing bone growth in mammals |
| 09/12/2000 | US6117838 Administering from about 30 to about 1,225 milligrams of intermolecularly- or intramolecularly-crosslinked stroma-free hemoglobin per kilogram of body weight to the mammal |
| 09/12/2000 | US6117837 Inhibiting proinflammatory cytokine production |
| 09/12/2000 | US6117836 Glycosylation-mediated inhibition of factor X |
| 09/12/2000 | US6117680 Compositions and methods for regulation of transcription |
| 09/12/2000 | US6117675 Retinal stem cells |
| 09/12/2000 | US6117662 Respiratory nitrate reductase alpha subunit |
| 09/12/2000 | US6117655 Nucleic acid encoding adhesion variants |
| 09/12/2000 | US6117654 Nucleotide sequence coding antiinflammatroy proteins; antiarthritic agents; antiinflammatory agents; bronchodilator agents |
| 09/12/2000 | US6117653 Hepatitis B surface antigen vaccine |
| 09/12/2000 | US6117650 Testing sample for defects heart muscle activity; coat well with nutrients, plate muscle cells, culture cells, insert test sample into culture, culture cells, monitor adjustment in cell size and release of atrial natriuretic protein |
| 09/12/2000 | US6117645 Human LH-RH receptor expression cells and use thereof |
| 09/12/2000 | US6117641 Assays and reagents for identifying anti-fungal agents and uses related thereto |
| 09/12/2000 | US6117633 Detecting nucleotide sequences coding antitumor protein; hyridizing sequences of normal and cancer cells, probing libraries with sequences, isolating and fragmenting clones, insertion in vectors, isolate specific nucleotide sequences |
| 09/12/2000 | US6117433 Use of compositions comprising stabilized biologically effective compounds |
| 09/12/2000 | US6117427 Administering immunogenic protein-alkaloid conjugate having indolo(4,3-fg)quinoline derivative |
| 09/12/2000 | US6117426 Human amine transporter polypeptide fragments |
| 09/12/2000 | US6117425 Supplemented and unsupplemented tissue sealants, method of their production and use |
| 09/12/2000 | US6117424 Compositions of mononuclear phagocytes useful for promoting axonal regeneration |
| 09/12/2000 | US6117423 Highly purified species of human leukocyte interferon |